March 2020 Archives

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Russian Federation Pharma – March 2020 update

June 8, 2020

Comments are off for this post.

News

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular updates and networking

Recent blog post.

Key Biopharma Deals of 2024

Posted: 9 hours ago
KYBORA Welcomes Stefan Bluemmers as Managing Director

Posted: 3 days ago
Accelerated Approval (AA) and PRV Grant: Implications of the FDA’s Updated Guidance

Posted: 1 week ago
Empowering Dreams through Foundation Rwanda’s KYBORA Program

Posted: 1 week ago
Navigating the Complexities of Priority Review Vouchers in the Context of Accelerated Approval Withdrawals

Posted: 4 weeks ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

Tell us about your business and corporate development needs.

Contact Us

KYBORA is a global advisory firm whose mission is to guide transformative healthcare companies to enduring success globally, by offering optimal M&A, licensing, fundraising and strategic advisory services in all key markets around the world.

About Us.

About KYBORA
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

Key Biopharma Deals of 2024

Posted: 9 hours ago
KYBORA Welcomes Stefan Bluemmers as Managing Director

Posted: 3 days ago

Terms of service | Privacy policy

Recent blog post.

Tags.

TYPE & ENTER: